Shadi Abu-Baker Selected Research

Carcinoma (Carcinomatosis)

4/2013	c-Myc phosphorylation by PKCζ represses prostate tumorigenesis.
8/2009	Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shadi Abu-Baker Research Topics

Disease

6	Neoplasms (Cancer) 07/2014 - 01/2009
2	Carcinoma (Carcinomatosis) 04/2013 - 08/2009
2	Carcinogenesis 08/2009 - 01/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Skin Neoplasms (Skin Cancer) 08/2012
1	Prostatic Neoplasms (Prostate Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

2	Interleukin-6 (Interleukin 6)IBA 07/2014 - 01/2009
2	TensinsIBA 04/2013 - 08/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2013 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 08/2012
2	SaposinsIBA 01/2013 - 08/2012
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2013 - 08/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2014
1	Amino Acids FDA Link 07/2014
1	Glucose (Dextrose)FDA LinkGeneric 07/2014
1	PhosphatidylserinesIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	NF-kappa B (NF-kB)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	Protein Kinases (Protein Kinase)IBA 01/2009
1	Protein Isoforms (Isoforms)IBA 01/2009
1	MitogensIBA 01/2009
1	PKC-3 proteinIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2013 - 08/2009
1	Subcutaneous Injections 08/2012